FMA Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-475
Closed -$247K 41
2024
Q3
$247K Sell
475
-25
-5% -$13.4K 0.18% 39
2024
Q2
$271K Hold
500
0.22% 39
2024
Q1
$259K Hold
500
0.21% 37
2023
Q4
$236K Buy
+500
New +$231K 0.21% 38

Other funds holding ELV

FMA Wealth Management's ELV Position: Q4 2024 in Review

FMA Wealth Management sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 475 shares — an estimated $247K sold.

FMA Wealth Management first reported a position in ELV in Q4 2023 and held it in 4 quarters. The position peaked at $271K in Q2 2024. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • FMA Wealth Management reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • FMA Wealth Management sold 475 Elevance Health shares in Q4 2024, an estimated $247K.
  • FMA Wealth Management first reported a position in Elevance Health in Q4 2023 and held it in 4 quarters.
  • FMA Wealth Management's Elevance Health position peaked at $271K in Q2 2024.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on FMA Wealth Management's 13F filing for Q4 2024, filed 3 Feb 2025.